Comparison of three galenic forms of
lamivudine in young West African children
living with Human Immunodeficiency Virus,
Auteur(s):
Claire Pressiat, Evelyne Dainguy, Jean-Marc Treluyer, Caroline Yonaba, Saik Urien, François Eboua, Frantz Foissac , Desire Lucien Dahourou, Naım Bouazza, Karen Malateste, Sophie Desmonde, Alain Pruvost, Valeriane Leroy, Deborah Hirt
Auteur(s) tagués:
CAROLINE OKENGO ;
Résumé
Background: Few pharmacokinetic data were reported on dispersible tablets despite their increasing use. One hundred
fifty HIV-infected children receiving lamivudine were enrolled in the MONOD ANRS 12,206 trial. Three galenic forms
were administered: liquid formulation, tablet form and dispersible scored tablet.
Method: HIV-infected children
Mots-clés
pharmacokinetics lamivudine children